Pharmaceutical.Report

TailorMed, a leading technology company offering the nation’s largest network of patients, providers, pharmacies, life science companies, and other partners dedicated to improving healthcare affordability, announced Eagle Pharmaceuticals, Inc. will be implementing TailorMed’s Express Enroll solution. This partnership will introduce new efficiencies in seeking to secure financial assistance for patients prescribed Eagle’s Pemfexy to manage and treat lung cancer.

Click here to read more: https://bit.ly/3s4SUl0

TailorMed Partners with Eagle Pharmaceuticals to Streamline TailorMed, a leading technology company offering the nation’s largest network of patients, providers, pharmacies, life science companies, a

Marium Qaiser, a Global Health and Life Sciences Consultant in drugs research and manufacture at GSK, explains the emergence of antimicrobial resistance and its effects on human health in low and middle-income countries. She emphasizes the need for multi-pronged approaches to address the AMR crisis.

To read more, click here: https://bit.ly/3Q5MzO1

Exploring the Rising Global Concern of Antimicrobial Resistance Explore the escalating global concern of antimicrobial resistance, its ramifications for health, and potential solutions in this comprehensive article.

Halozyme Therapeutics, Inc. announced positive results of a clinical study demonstrating subcutaneous administration of 10 mL of a representative biologic product co-formulated with its ENHANZE® drug delivery technology, in approximately 30 seconds. In the study, the biologic was delivered with Halozyme's proprietary high-volume auto-injector (HVAI) in healthy volunteers. The injection was delivered successfully to all 23 participants and was well tolerated.

Click here to read the full article now: https://bit.ly/3ty9gCS

Halozyme Announces Positive Clinical Data of its High-Volume Halozyme Therapeutics, Inc.announced positive results of a clinical study demonstrating subcutaneous administration of 10 mL of a representative biologic

MEDIA 7’s The Pharmaceutical Report extends a warm invite to the ‘Global Pharma Supply Chain & Logistics Forum 2023’ in Germany.

The GPSF - Global Pharma Supply Chain & Logistics Forum, organized by Brainlinx, is the world’s leading event for exploring and enhancing the pharmaceutical supply chain and logistics industry. This 2-day forum brings together experts and professionals from various sectors and regions to share their insights, best practices, and innovations on how to optimize the pharma chain and logistics processes.

The event at the NH Collection Berlin Friedrichstrasse will cover topics such as Pharma Supply Chain & Logistics Awards, digital transformation, artificial intelligence, machine learning, blockchain, data analytics, quality management, risk mitigation, sustainability, and customer satisfaction.

More details are available at: https://bit.ly/45xFtaN

Featured Speakers: Jitendra Kumar | Vikram Matharoo | Tony Hawkes | Matthias Verstraeten | Artur Schmidt | Demet Tazegul | Cser Aliz | Saurabh Verma | Robert Kayum | Bernhard Salb

Date: October 19- 20, 2023
In-person
[email protected] | BrainLinx (BLX)

Register now: https://bit.ly/45xFtaN

Global Pharma Chain & Logistics Forum Join us at Pharma Supply Chain & Logistics Forum in for a two-day journey

BioMap announced a groundbreaking strategic collaboration with Sanofi to co-develop cutting-edge AI modules for biotherapeutic drug discovery leveraging BioMap’s AI platform.

Be in the know and click here to learn more about this news: https://bit.ly/3tyOq6C

BioMap Establishes a Strategic Collaboration with Sanofi BioMap announced a groundbreaking strategic collaboration with Sanofi to co-develop cutting-edge AI modules for biotherapeutic drug discovery

Indivior, a leading addiction treatment company, has gained exclusive global rights to develop, manufacture, and commercialize 昱展新藥 Alar Pharmaceuticals Inc. Inc.'s portfolio of long-acting injectable formulations that release a prodrug of buprenorphine at varying durations, including its lead long-acting injectable candidate, ALA-1000.

Click the link below to read the full news:
https://bit.ly/3FgJXYS

Indivior Enters an Exclusive Licensing Agreement with Alar Indivior PLC a leading addiction treatment company, announced that it has gained exclusive global rights to develop,

Iambic Therapeutics, a biotech company developing novel therapeutics from its unique generative AI discovery platform, has announced the closing of an oversubscribed $100 million Series B financing co-led by Ascenta Capital and Abingworth, and including new investors NVIDIA, Illumina Ventures, gradiant corporation, and independent board member Bill Rastetter.

Click the link below to read the full news:
https://bit.ly/3F9FLtR

Iambic Therapeutics Announces Close of Oversubscribed $100 Million Iambic Therapeutics a biotechnology company developing novel therapeutics from its unique generative AI discovery platform, today announced the closing

MEDIA 7’s The Pharmaceutical.Report is elated to extend a heartfelt invitation to the ‘MedFIT 2023’ at Strasbourg, France.

The MedFIT - MedTech, Diagnostic and Digital Health Innovation Forum, organized by Eurasanté, is the European event dedicated to fostering partnerships and innovation in the fields of MedTech, Diagnostic and Digital Health. This 2-day forum gathers key players of the sectors such as investors, start-ups, big companies, research actors and many others to network, exchange ideas and collaborate on projects.

The event at the Palais de la Musique et des Congrès will feature topics such as: MedFIT Awards, ethical standards, quality management, risk mitigation, sustainability and customer satisfaction. It will also include an exhibition area, a start-up slam contest and one-on-one meetings.

More details are available at: https://bit.ly/3rHXdT4

Featured Speakers: Adriana Díaz Martín-Zamorano | Anna Erat (MD, PhD, IDP INSEAD) | Arjan van Manen | Artur Olesch | Carole Absil | Charles-Eric Winandy | Charlotte Puechmaille | Colm Coffey | Cyril Teixeira da Silva | Dorothée Moisy-Gouarin and many more.

Date: October 10 – 11, 2023
In-person
Valentine Delabie | Eurasanté

Register now: https://bit.ly/3rHXdT4

MedFIT 2023 MedFIT is your unique opportunity to connect with international

MEDIA 7's The Pharmaceutical.Report invites you to be a part of the 3rd Saudi International Pharma Expo 2023, set to take place in Riyadh, Saudi Arabia, Riyadh International Convention and Exhibition Center (RICEC) from October 9th to 11th, 2023.

Join this leading event and explore the entire laboratory industry value chain, from raw materials to finished formulations, distributors, and healthcare networks. Engage with industry innovations and connect with leaders, researchers, and peers.

More details are available at: https://bit.ly/3F7152V

Date: October 09-11, 2023
In-Person
Reema Sakkijha | 1st Arabia Tradeshows & Conferences

Register now: https://bit.ly/3F7152V

3rd Saudi International Pharma Expo Pharma is committed to providing a complete solution to the Laboratory industry.

MEDIA 7's The Pharmaceutical.Report invites you to be a part of the 9th Pharma Packaging and Labeling Innovation Forum 2023, set to take place in Berlin, Germany, from October 5th to 6th, 2023.

Join this leading event to gain valuable insights on key industry challenges for material & design innovations, sustainability, branding & marketing, as well as inspirational & active packaging.

More details are available at: https://bit.ly/3RJhIcI

Featured Speakers: Nurit Nahum, PhD | Dario Kulić | Michiel van den Berg | Christina Montjoly | Kathrin Gallistl-Burandt | Anne Uusitalo | Simon Cavanagh | Steven Brookes | Chiara T. | Sabine Faber, PhD and many others..

Date- 5-6th Oct, 2023
Format- In – person
Organizer- BrainLinx

Register now: https://bit.ly/3RJhIcI

9th Pharma Packaging And Labeling Innovation Forum 9th Pharma Packaging And Labeling Innovation Forum 2023 is an executive platform to discuss the industry

Aquestive Therapeutics announces FDA acceptance of new drug application for Libervant™ (diazepam) Buccal Film for pediatric patients between two and five years of age.

Click the link below to read the full news:
https://bit.ly/3RfZE9F

Aquestive Therapeutics Receives FDA Acceptance of New Drug Aquestive Therapeutics, Inc. a pharmaceutical company advancing medicines to solve patients

MEDIA 7's The Pharmaceutical.Report cordially invites you to be a part of the 10th Pharma Packaging and Labeling Innovation Forum 2023, set to take place in Boston, Massachusetts, from September 14th to 15th, 2023.

This prestigious event brings together senior packaging professionals across the supply chain to engage in meaningful discussions on a range of critical topics, including material & design innovations, sustainability, branding & marketing, and inspirational & active packaging.

More details are available at: https://tinyurl.com/ympe3hms

Featured Speakers: Suzanne Ivory | Weiner Tilsner | Yuricel Tamayo Alvarez | Urimara Argotti | Cham Williams | Nélio Drumond, PharmD, PhD | Camille DISS | Tara Baer | Samantha Thompson | Virginia A Lang | Asmita Khanolkar

Date: September 14-15, 2023
Physical | BrainLinx

Register now: https://tinyurl.com/ympe3hms

10th Pharma Packaging And Labeling Innovation Forum (USA) 10th Pharma Packaging and Labeling Innovation Forum 2023 is an executive platform to discuss the industry